SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-152435
Filing Date
2021-05-06
Accepted
2021-05-06 06:56:03
Documents
14
Period of Report
2021-05-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d382277d8k.htm   iXBRL 8-K 24501
2 EX-99.1 d382277dex991.htm EX-99.1 84326
6 GRAPHIC g382277g99g88.jpg GRAPHIC 3321
  Complete submission text file 0001193125-21-152435.txt   249325

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA epzm-20210506.xsd EX-101.SCH 3065
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE epzm-20210506_lab.xml EX-101.LAB 18137
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE epzm-20210506_pre.xml EX-101.PRE 11404
7 EXTRACTED XBRL INSTANCE DOCUMENT d382277d8k_htm.xml XML 3342
Mailing Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139 617-229-5872
Epizyme, Inc. (Filer) CIK: 0001571498 (see all company filings)

IRS No.: 261349956 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35945 | Film No.: 21895682
SIC: 2834 Pharmaceutical Preparations